NIH Funding · FY2024
Total Funding
$2M
Fiscal year 2024
Grants Awarded
2
Active NIH grants
National Rank
#5,368
Among 57,894 PIs
First NIH Award
2024
Year of first funding
Funding & rank history
NIH funding totals and national rank by fiscal year.
Single fiscal year on record (FY2024): $2M across 2 grants · National rank #5368.
Top grants by award amount
Xinmin Simon Xie's NIH grant portfolio, ranked by award amount.
- 5R44NS132642-02R44Clinical Phase I trials on an IND single molecule dual inhibitor of Cav3 channels and soluble epoxide hydrolase for treatment of neuropathic pain$1.5Maward amount
- 5U43AA031391-02U43Development of a Novel Medication for Alcohol Use Disorder with an Active IND Dual Inhibitor of T-Type Calcium Channel and Soluble Epoxide Hydrolase$498.9Kaward amount
Affiliation
Institutions that have administered grants for Xinmin Simon Xie.
Affiliated with Afasci, Inc. (CA).
Career milestones
Key NIH funding milestones over time.
- 2024First NIH AwardAfasci, Inc.
- 2024$500K Cumulative Funding
- 2024$1M Cumulative Funding
- 2024Entered Top 50% NationallyRanked #5368
Related investigators
Other NIH-funded PIs frequently associated with Xinmin Simon Xie.
Explore further
Find collaborators for Xinmin Simon Xie
Search NIH-funded principal investigators by topic, department, or activity.
Open Find Collaborators →Check S10 eligibility at Afasci, Inc.
Review past S10 Shared Instrumentation Grant awards and equipment categories.
Open S10 Eligibility Finder →Benchmark grant budgets
Compare median NIH grant budgets across departments, mechanisms, and years.
Open Grant Budget Benchmark →